COMMUNIQUÉ DE PRESSE
par Thyssenkrupp Nucera AG & Co. KGaA (isin : DE000NCA0001)
thyssenkrupp nucera recorded strong sales growth and slightly better-than-expected earnings in Q4 and FY 2023/24; project execution well on track
EQS-News: thyssenkrupp nucera AG & Co. KGaA / Key word(s): Preliminary Results
thyssenkrupp nucera recorded strong sales growth and slightly better-than-expected earnings in Q4 and FY 2023/24; project execution well on track
18.11.2024 / 18:01 CET/CEST
The issuer is solely responsible for the content of this announcement.
TRADING STATEMENT: thyssenkrupp nucera recorded strong sales growth and slightly better-than-expected earnings in Q4 and FY 2023/24; project execution well on track
Q4 2023/24: Strong performance in the last quarter with positive order intake momentum, strongly growing alkaline water electrolysis (AWE) sales and resilient profitability
FY 2023/24:
All statements reported herein are preliminary and unaudited. Full financial disclosure for Q4/FY 2023/24 will be published as planned on 17 December 2024 at 07:00 am CET.
Q4 2023/24: Strong performance in the last quarter with positive order intake momentum, strongly growing alkaline water electrolysis (AWE) sales and resilient profitability
- Growing order intake driven by Chlor-Alkali (CA) service business; AWE order intake on prior year’s level
- Strong year-on-year sales growth due to AWE business; AWE sales doubled in Q4 and thereby reached a new all-time high, reflecting significant progress of projects under execution; CA sales roughly on par with previous year
- EBIT below prior year, but slightly better than expected; EBIT decline due to planned ramp-up costs and lower gross margin in line with higher AWE sales share, partly offset by strong margins in CA business and cost containment
FY 2023/24:
- Order intake slightly above prior year’s level, largely driven by the AWE project with Stegra (H2 Green Steel) in Sweden; CA order intake fell from the previous year’s record high, which was supported by the large OxyChem project in the US
- Group sales guidance of 820mn € to 900mn € reached as well as AWE sales target of 500mn € to 550mn €; both sales figures came in roughly in the middle of the range
- Strong sales increase mostly driven by the dynamic sales growth in the AWE business following ongoing execution of projects, especially in Saudi Arabia and Sweden
- CA sales slightly above prior year’s level
- EBIT slightly better than originally expected (guidance: negative EBIT figure in mid double-digit mn € range)
- Significant year-on-year EBIT decline mainly due to the planned organizational ramp-up and AWE capacity build-up, higher R&D expenditures as well as the increased share of AWE sales, which is currently still accompanied by lower gross margins
- Successful CA business delivered healthy profit margins and thereby supported the expansion towards green hydrogen
All statements reported herein are preliminary and unaudited. Full financial disclosure for Q4/FY 2023/24 will be published as planned on 17 December 2024 at 07:00 am CET.
18.11.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | thyssenkrupp nucera AG & Co. KGaA |
| Freie-Vogel-Str. 385 a | |
| 44269 Dortmund | |
| Germany | |
| Phone: | +49 231-22972-7100 |
| E-mail: | info@thyssenkrupp-nucera.com |
| Internet: | www.thyssenkrupp-nucera.com |
| ISIN: | DE000NCA0001 |
| WKN: | NCA000 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2032301 |
| End of News | EQS News Service |
2032301 18.11.2024 CET/CEST